Nuvectis Pharma, Inc. (NVCT) Earnings
|
Expand Research on NVCT
| Next EPS Date | 5/8/24 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -2,632.6% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5/8/24 | Q124 | N/A | -$0.40 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/5/24 | Q423 | N/A | -$0.36 | N/A | N/A | N/A | N/A | N/A | N/A | ||
11/8/23  |
Q323 | -$0.37 | -$0.34 | -$0.03 | N/A | N/A | N/A |  | | Details | |
| 8/4/23 | Q223 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/7/23 | Q223 | N/A | -$0.29 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 5/9/23 | Q123 | N/A | -$0.44 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 3/21/23 | Q422 | N/A | -$0.39 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 11/30/22 | Q322 | N/A | -$0.26 | N/A | N/A | $-90 | N/A | N/A | N/A |
